Pharmacovigilance and Post Authorisation Safety 

This part of our website includes pharmacovigilance and post authorisation safety information for marketing authorisation holders. It provides details in respect of EU legislation, national reporting of adverse reactions, periodic safety update reports and post authorisation safety studies. Further information relating to risk management plans is also provided as are details of EMA signal assessment and recommendations.